Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy
Journal of Cancer Research and Clinical Oncology · 2024-09-07 · 150 (9)
DOI: 10.1007/s00432-024-05932-x ↗At a glance
Journal article in Journal of Cancer Research and Clinical Oncology, published online on 2024-09-07. Written by Guomin Gu and 6 co-authors. Institution: Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xincheng District, Urumqi, X…. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Proto-Oncogene Proteins p21(ras), Lung Neoplasms, Mutation. Cited 8 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region, Department of Science and Technology of Xinjiang Uygur Autonomous Region.
Abstract (original language)
Kokkuvõte pole saadaval.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xincheng District, Urumqi, Xinjiang, 830011, China.
- Education and Research Management Office, Affiliated Cancer Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xincheng District, Urumqi, Xinjiang, 830011, China.
- Department of Breast and Thyroid Surgery, Affiliated Cancer Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xincheng District, Urumqi, Xinjiang, 830011, China. sung853219@126.com.
- Xinjiang Cancer Center/Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region, Urumqi, Xinjiang, 830011, China. sung853219@126.com.
Funding
- Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region
- Department of Science and Technology of Xinjiang Uygur Autonomous Region
Cite
APA
Gu, G., Liu, C., Zhu, X., Yang, Y., Song, S., Zhao, Y., & Sun, G. (2024). Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of Cancer Research and Clinical Oncology, 150(9). https://doi.org/10.1007/s00432-024-05932-x
Vancouver
Gu G, Liu C, Zhu X, Yang Y, Song S, Zhao Y, et al. Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of Cancer Research and Clinical Oncology. 2024;150(9). doi:10.1007/s00432-024-05932-x
BibTeX
@article{Gu2024,
author = {Gu, Guomin and Liu, Chunling and Zhu, Xiaodan and Yang, Yan and Song, Shuming and Zhao, Yan and Sun, Gang},
title = {Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
volume = {150},
number = {9},
doi = {10.1007/s00432-024-05932-x}
}
EUVIMED